deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT01102140

The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study (ImPrOVE)

The Impact of Pomegranate (Punica Granatum) Polyphenol Extract on Oxidative Stress, Ventricular Remodeling and Endothelial Function in Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study

Sponsor: Jennifer Cowger , MD, MS

Conditions Cardiomyopathy Heart Failure
Interventions POMx, pomegranate polyphenol extract Sugar Pill
Updated 7 times since 2017 Last updated: Jun 13, 2017 Started: Jul 31, 2010 Primary completion: May 31, 2013 Completion: May 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Investigator left University of Michigan

This PHASE2 trial investigates Cardiomyopathy and Heart Failure and is currently terminated or withdrawn. Jennifer Cowger , MD, MS leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotUnknown Status~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Aug 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    Status: Unknown Status → Terminated

▶ Show 2 earlier versions

  1. Feb 2017 — Aug 2017 [monthly]

    Unknown Status PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jennifer Cowger , MD, MS
  • POM Wonderful LLC
Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations